| mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.008 |
| mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.009 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.03 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.03 |